Fate of Glenmark's Crofelemer uncertain on legal dispute
Pharma major Glenmark's drug Crofelemer promises huge opportunities but its marketing partners Napo Pharma and Salix Pharma are embroiled in a legal dispute. This is likely to affect its launch in the market.
